uk-plab-1 MCQ (SBA): Type 2 diabetes – SGLT2 inhibitor use

Instant feedback + full explanation. One question, done properly.

ModerateEndocrinologyType 2 diabetes – SGLT2 inhibitor useuk-plab-1

A 65-year-old man with type 2 diabetes and established ischaemic heart disease is taking Metformin at maximum tolerated dose. His HbA1c remains 71 mmol/mol. According to current NICE guidance, which additional class of drug is most appropriate to add?

Educational content. Not a substitute for clinical judgement or local policy.